[1]
Parmar, M.T. 2026. Low Beta Is Not Low Risk: Evidence and Investor Implications from Five Indian Pharmaceutical Stocks, 2021–2025. International Journal of Engineering and Management Research. 16, 3 (Jun. 2026), 113–125. DOI:https://doi.org/10.31033/IJEMR/16.3.2026.1941.